Physician profile
Hua Jiang
NPI 1821072844
$3,950.48
in general payments reported to CMS, 2019-2025
15 companies · $591 in 2025
The $591 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $696 · 2020: $680 · 2021: $436 · 2022: $406 · 2023: $498 · 2024: $644 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,658 · Education: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,657.60 |
| Education | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $856.33 | 2019-2025 | Veklury |
| Merck Sharp & Dohme LLC | $760.02 | 2019-2025 | Zerbaxa, Recarbrio, Dificid |
| Viiv Healthcare Company | $703.96 | 2019-2025 | Dovato, Cabenuva |
| Allergan, INC. | $426.61 | 2019-2020 | |
| Abbvie INC. | $330.86 | 2021-2025 | |
| Insmed, INC. | $294.95 | 2019-2025 | Arikayce, Brinsupri |
| Shionogi INC | $192.84 | 2021-2025 | Fetroja |
| La Jolla Pharmaceutical Company | $125.67 | 2020-2022 | |
| Baxter Healthcare | $79.40 | 2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care |
| Tetraphase Pharmaceuticals, INC. | $52.23 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $33.96 | 2019-2025 | Nuzyra |
| Melinta Therapeutics, LLC | $32.12 | 2023 | Vabomere, Rezzayo, Kimyrsa |
| Nabriva Therapeutics, Plc | $22.71 | 2020 | |
| Theratechnologies INC. | $19.61 | 2021 | |
| Janssen Biotech, INC. | $19.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hua Jiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.